Empery Asset Management’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-12
Closed -$58K – 77
2022
Q1
$58K Buy
+12
New +$63K 0.27% 44

Other funds holding MTRI

Empery Asset Management's MTRI Position: Q2 2022 in Review

Empery Asset Management sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q2 2022, closing a stake of 12 shares — an estimated $58K sold.

Empery Asset Management first reported a position in MTRI in Q1 2022 and held it in 1 quarter. The position peaked at $58K in Q1 2022. 6 funds tracked by Wall St. Rank hold MTRI as of Q2 2022.

  • Empery Asset Management reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Empery Asset Management sold 12 Mentari Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $58K.
  • Empery Asset Management first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Empery Asset Management's Mentari Therapeutics, Inc. Common Stock position peaked at $58K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Empery Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.